Henry not only opened up the conference, but also participated in a panel later on in the event. The panel session was titled “Capital formation strategies for stem cell and regenerative medicine companies” and was part of the event segment focused on access to capital gap. The panel was moderated by Robin Smith, Chairman and Chief Executive Officer of NeoStem. Other participants included:
- Stephen Brozak, President, WBB Securities
- Matthew Vincent, Director, Business Development, Advanced Cell Therapy
- Chris Airriess, Chief Development Officer, California Stem Cell
As Founder and Director of Research, Henry McCusker has already entered his twelfth year at Scimitar Equity, LLC. His past experience in sell-side analysis, buy-side management and due diligence provide keen insight and define a unique ability as a research provider.
The 6th annual Stem Cells & Regenerative Medicine Congress is where pharma, biotech, academia, government and investors come to uncover the technologies, strategies and business models that will help get stem cell and regenerative medicine treatments to market faster and more cost effectively.
This year’s event will take place September 15-16 in Boston, MA. We hope to see you there!